RINVOQ® Approved by European Commission as an Oral Treatment for Adults with Active Non-Radiographic Axial Spondyloarthritis Pharmaceutical Investing
Biktarvy® Demonstrates High Efficacy for a Broad Range of People Initiating Treatment for HIV, Including Those With HBV Coinfection Pharmaceutical Investing
AbbVie Submits Regulatory Applications to FDA and EMA for Upadacitinib in Crohn's Disease Pharmaceutical Investing
The Gummy Project Secures First Repeat Order from Existing Customer Bard on the Beach Life Science Investing
European Commission Approves RINVOQ® for the Treatment of Adults With Moderate to Severe Ulcerative Colitis Pharmaceutical Investing
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Sharps Compliance Corp. , Infrastructure and Energy Alternatives, Inc. , AutoWeb, Inc. , Zymergen Inc. Life Science Investing
Aurinia Pharmaceuticals to Release Second Quarter 2022 Financial and Operational Results on August 4, 2022 Pharmaceutical Investing
